What is Bicara Therapeutics's market capitalization?

Bicara Therapeutics (BCAX) reported market capitalization of $1.29B in Q1 2026.

How has Bicara Therapeutics's market capitalization changed year-over-year?

Bicara Therapeutics's market capitalization increased by 81.4% year-over-year, from $710.44M to $1.29B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Bicara Therapeutics BCAX Market capitalization

Market capitalization at other companies

Eli LillyLLY

$821.68B+10.8%

AmgenAMGN

$189.67B+13.3%

ArriVent BioPharma, Inc.AVBP

$1.02B+62.1%

ImmunomeIMNM

$2.47B+323%

Arcus BiosciencesRCUS

$2.71B+226%

Syndax PharmaceuticalsSNDX

$2.06B+95.0%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Enterprise value$1.32B+288%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Computed from the period-end share price: $1.29B.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's market capitalization?: Bicara Therapeutics (BCAX) reported market capitalization of $1.29B in Q1 2026.
How has Bicara Therapeutics's market capitalization changed year-over-year?: Bicara Therapeutics's market capitalization increased by 81.4% year-over-year, from $710.44M to $1.29B.
What does market capitalization mean?: The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.